ODONATE THERAPEUTICS INC - COM (ODTC) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2017 to Q2 2022

Type / Class
Equity / COM
Symbol
ODTC on OTC
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ODONATE THERAPEUTICS INC - COM (ODTC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2022 Q2 0 $0 -$7,135,000 0
2022 Q1 5,407,518 $7,135,000 -$25,420,780 $1.32 6
2021 Q4 24,240,291 $32,725,157 -$18,349,949 $1.35 44
2021 Q3 32,624,093 $94,944,045 -$1,699,253 $2.91 52
2021 Q2 32,946,494 $114,995,253 +$913,997 $3.49 62
2021 Q1 32,621,179 $111,559,327 -$181,379,391 $3.42 71
2020 Q4 38,385,136 $736,980,157 +$29,552,695 $19.20 90
2020 Q3 36,995,474 $496,915,533 +$49,248,636 $13.43 86
2020 Q2 30,652,552 $1,294,296,002 -$3,274,750 $42.34 90
2020 Q1 30,744,181 $848,110,476 -$15,819,604 $27.61 76
2019 Q4 31,260,366 $1,014,405,096 -$5,258,154 $32.45 86
2019 Q3 31,434,144 $818,219,184 +$7,899,492 $26.03 78
2019 Q2 31,074,141 $1,140,087,341 +$243,026,639 $36.69 76
2019 Q1 24,461,703 $540,848,883 -$7,566,525 $22.11 55
2018 Q4 24,631,869 $346,815,577 -$3,868,931 $14.08 52
2018 Q3 24,737,561 $480,152,154 -$602,251 $19.41 51
2018 Q2 10,957,385 $241,952,725 +$23,579,176 $22.08 48
2018 Q1 9,892,734 $208,429,030 +$7,117,341 $21.18 42
2017 Q4 9,491,975 $235,617,000 +$235,617,000 $25.00 26